These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23620163)

  • 21. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
    Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT
    Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis.
    Philipp S; Sosna J; Plenge J; Kalthoff H; Adam D
    Cell Commun Signal; 2015 Apr; 13():25. PubMed ID: 25925126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.
    Vinarsky V; Krivanek J; Rankel L; Nahacka Z; Barta T; Jaros J; Andera L; Hampl A
    Stem Cells Dev; 2013 Nov; 22(22):2964-74. PubMed ID: 23806100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells.
    Zhou W; Feng X; Han Han ; Guo S; Wang G
    Sci Rep; 2016 Jun; 6():28004. PubMed ID: 27292433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effect of histone deacetylase inhibitor suberoylanilide hydroxamic acid and anti-CD20 monoclonal antibody rituximab on mantle cell lymphoma cells apoptosis.
    Shi W; Han X; Yao J; Yang J; Shi Y
    Leuk Res; 2012 Jun; 36(6):749-55. PubMed ID: 22475365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation.
    Carlisi D; Lauricella M; D'Anneo A; Emanuele S; Angileri L; Di Fazio P; Santulli A; Vento R; Tesoriere G
    Eur J Cancer; 2009 Sep; 45(13):2425-38. PubMed ID: 19643600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo.
    Nagane M; Pan G; Weddle JJ; Dixit VM; Cavenee WK; Huang HJ
    Cancer Res; 2000 Feb; 60(4):847-53. PubMed ID: 10706092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.
    Kong X; Luo J; Xu T; Zhou Y; Pan Z; Xie Y; Zhao L; Lu Y; Han X; Li Z; Liu L
    Oncol Rep; 2017 Jun; 37(6):3423-3432. PubMed ID: 28498435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms.
    Zhang W; Pelicano H; Yin R; Zeng J; Wen T; Ding L; Huang R
    Mol Med Rep; 2015 Nov; 12(5):7374-88. PubMed ID: 26458979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SAHA-sensitized prostate cancer cells to TNFalpha-related apoptosis-inducing ligand (TRAIL): mechanisms leading to synergistic apoptosis.
    Lakshmikanthan V; Kaddour-Djebbar I; Lewis RW; Kumar MV
    Int J Cancer; 2006 Jul; 119(1):221-8. PubMed ID: 16450389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells.
    Steinwascher S; Nugues AL; Schoeneberger H; Fulda S
    Cancer Lett; 2015 Sep; 366(1):32-43. PubMed ID: 26028172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia.
    Kuroda I; Inukai T; Zhang X; Kikuchi J; Furukawa Y; Nemoto A; Akahane K; Hirose K; Honna-Oshiro H; Goi K; Kagami K; Yagita H; Tauchi T; Maeda Y; Sugita K
    Oncogene; 2013 Mar; 32(13):1670-81. PubMed ID: 22665066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL.
    Yerbes R; López-Rivas A
    Invest New Drugs; 2012 Apr; 30(2):541-7. PubMed ID: 21107885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A.
    Lu MC; Du YC; Chuu JJ; Hwang SL; Hsieh PC; Hung CS; Chang FR; Wu YC
    Arch Toxicol; 2009 Feb; 83(2):121-9. PubMed ID: 18709356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.
    Yu C; Rahmani M; Almenara J; Subler M; Krystal G; Conrad D; Varticovski L; Dent P; Grant S
    Cancer Res; 2003 May; 63(9):2118-26. PubMed ID: 12727828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ
    Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts.
    Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM
    Int J Mol Med; 2005 Dec; 16(6):1041-8. PubMed ID: 16273284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair.
    Maiso P; Colado E; Ocio EM; Garayoa M; Martín J; Atadja P; Pandiella A; San-Miguel JF
    Leukemia; 2009 Dec; 23(12):2265-74. PubMed ID: 19812608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homoharringtonine acts synergistically with SG235-TRAIL, a conditionally replicating adenovirus, in human leukemia cell lines.
    Meng HT; Li L; Liu H; Wang Y; Li GC; Qian WB
    Acta Pharmacol Sin; 2009 Nov; 30(11):1529-36. PubMed ID: 19820719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis.
    Koyama M; Izutani Y; Goda AE; Matsui TA; Horinaka M; Tomosugi M; Fujiwara J; Nakamura Y; Wakada M; Yogosawa S; Sowa Y; Sakai T
    Clin Cancer Res; 2010 Apr; 16(8):2320-32. PubMed ID: 20371690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.